Skip to content

WAS WORLD'S THROAT CUT? Ebola vaccine research was earlier abandoned

By Catholic Online (NEWS CONSORTIUM)
8/7/2014 (2 years ago)
Catholic Online (www.catholic.org)

Experimental vaccines were successful on monkeys four years ago

With increasing fears of the Ebola virus in West Africa and elsewhere, world governments are now frantically trying to contain the disease. What is not widely known is the fact that there had been work on finding a vaccine for Ebola four years ago, that was initially met with success in monkeys. Has the world's throat been cut by abandoning this research?

It must also be noted that while the National Institutes of Health and the U.S. government often fund the early animal safety and efficacy testing of a vaccine, pharmaceutical companies typically fund the human clinical trials to take a drug or vaccine to market.

It must also be noted that while the National Institutes of Health and the U.S. government often fund the early animal safety and efficacy testing of a vaccine, pharmaceutical companies typically fund the human clinical trials to take a drug or vaccine to market.

Highlights

By Catholic Online (NEWS CONSORTIUM)
Catholic Online (www.catholic.org)
8/7/2014 (2 years ago)

Published in Health

Keywords: Ebola, vaccine, clinical trials, outbreak


LOS ANGELES, CA (Catholic Online) - A team of U.S. government scientists at that time developed vaccine candidates that shielded monkeys from multiple strains of Ebola. Those vaccines were never tested in human clinical trials. This in spite of the fact that one strain had a 100 percent success rate of protecting the animals from the disease.

The factor preventing such trials in humans, according to Dr. Daniel Bausch, an associate professor of tropical medicine at the Tulane University School of Public Health, has been cost.

SAVE Iraqi Christians from Genocide --

Currently stationed at the U.S. Naval Medical Research Unit 6 in Lima, Peru, Bausch says "When you have a population or situation with Ebola where it only sporadically occurs, and it occurs really in the world's poorest populations, it's not exactly an attractive candidate for the pharmaceutical industry on the economic side.

"We have good vaccine candidates, and some good drug candidates that have gone through fairly extensive testing for Ebola, and at least reduce the mortality rate in monkeys."
 
It must also be noted that while the National Institutes of Health and the U.S. government often fund the early animal safety and efficacy testing of a vaccine, pharmaceutical companies typically fund the human clinical trials to take a drug or vaccine to market.

One experimental Ebola vaccine is now being fast-tracked, according to National Institute of Allergy and Infectious Diseases director Anthony Fauci. Tragically, it could be years before its safety and effectiveness in humans is firmly established.

According to Nancy Sullivan, chief of the Biodefense Research Section of NIAID's Vaccine Research Center, another challenge of coming up with a vaccine to treat a deadly virus like Ebola is that researchers can't easily - or ethically - test it on humans.

"We obviously can't expose people to the Ebola virus" in order to know whether a vaccine is effective, Sullivan said. The alternative is to vaccinate high-risk human populations as a means of testing such a drug. But that's also problematic because Ebola outbreaks are so sporadic and hard to predict - "unless we vaccinate all of Africa, which isn't feasible," she said.

---


'Help give every student and teacher Free resources for a world-class moral Catholic education'


Copyright 2017 - Distributed by THE CALIFORNIA NETWORK

Pope Francis Prayer Intentions for MARCH 2017
Support for Persecuted Christians.
That persecuted Christians may be supported by the prayers and material help of the whole Church.


Comments


More Health

Two-thirds of cancers may have a surprising cause that we can do nothing about Watch

Image of Scientists have found that two-thirds of all cancer cases may be the result of random, bad-luck mutations.

If you are afraid of cancer, we have bad news. There may be little way to avoid the dreaded disease. A new study affirms that two-thirds of ... continue reading


Neil Gorsuch and end-of-life care: What ethical stance does he take? Watch

Image of Neil Gorsuch offers his views on end-of-life care.

Supreme Court nominee Neil Gorsuch made a crucial ethical distinction in his response to questions about doctor-prescribed suicide during ... continue reading


'Three-parent babies' are coming. We are resistant to wisdom, let's pray we are resistant to the consequences Watch

Image of Designer babies have arrived.

British doctors have been given the OK to create embryos from three parents to prevent genetic diseases. The first such child could be born ... continue reading


California could REBEL against Obama AND Trump and build its own single payer system, but who will pay for it? Watch

Image of California may be going alone on several things as the Federal government cuts back what it does for the states.

California is a large, wealthy state dominated by Democrats. Its economy, even if a bad year, is among the top ten in the world. The state ... continue reading


31-year-old man regains life after 'miraculous' face transplant Watch

Image of

After ten years, a 60-person medical team, and a 56-hour surgery, 31-year-old Andy Sandness received the first steps into truly getting his ... continue reading


Never Miss any Updates!

Stay up to date with the latest news, information, and special offers.

Catholic Online Logo

Copyright 2017 Catholic Online. All materials contained on this site, whether written, audible or visual are the exclusive property of Catholic Online and are protected under U.S. and International copyright laws, © Copyright 2017 Catholic Online. Any unauthorized use, without prior written consent of Catholic Online is strictly forbidden and prohibited.